Kabra Drugs Ltd

📈 Kabra Drugs Ltd Appoints Independent Director & Diversifies Business

- Appointment of Ms. Monam Kapoor (DIN: 09278005) as Non-Executive Independent Director for a five-year term from April 21, 2026, to April 20, 2031.

- Diversification of business approved, including drones & defence equipment, AI technologies, hospitals & e-pharmacy, hospitality, dairy products, and agro farms.

- Amendment of Memorandum of Association to add 12 new business objects, subject to shareholder and regulatory approvals.

- Postal ballot notice approved for changing company name and altering the object clause of the MOA.

- Book closure for shareholders from May 9, 2026, to June 8, 2026, with e-voting from May 9, 2026 (9:00 AM) to June 8, 2026 (5:00 PM).

- Appointment of M/s. Jay Jain & Associates as scrutinizer for the postal ballot process.

- Engagement of M/s. PPN And Company for compliance certification under SEBI regulations.